Prevalence of two tumor necrosis factor gene polymorphisms in premature infants with early onset sepsis

Biology of the Neonate

Volumn 90, Issue 4, 2006, Pages 229-232

  Schueller, A C ^a   Heep, A ^a,e   Kattner, E ^b   Kroll, M ^d   Wisbauer, M ^a   Sander, J ^c   Bartmann, P ^a   Stuber, F ^a  

^a UNIVERSITY OF BONN   (Germany)

^b KINDERKRANKENHAUS AUF DER BULT   (Germany)

^c Screening Laboratory   (Germany)

^d OLGAHOSPITAL   (Germany)

^e UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

Polymorphism; Preterm infant; Sepsis, early onset; TNF promoter, 308; TNF gene; Tumor necrosis factor

Indexed keywords

LYMPHOTOXIN; TUMOR NECROSIS FACTOR ALPHA;

ALLELE; ARTICLE; CONTROLLED STUDY; DEVELOPMENTAL SCREENING; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; GESTATIONAL AGE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; NEWBORN; NEWBORN SEPSIS; PREMATURITY; PRIORITY JOURNAL; PROMOTER REGION; RETROSPECTIVE STUDY; RISK ASSESSMENT;

ADULT; DOUBLE-BLIND METHOD; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; LYMPHOTOXIN-ALPHA; MALE; POLYMORPHISM, GENETIC; PREVALENCE; RETROSPECTIVE STUDIES; SEPSIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33751169140     PISSN: 00063126     EISSN: None     Source Type: Journal    
DOI: 10.1159/000093605     Document Type: Article

References (8)

1. Stoll BJ, Hansen NI, Adams-Chapman I, Fanaroff AA, Hintz SR, Vohr B, Higgins RD; National Institute of Child Health and Human Development Neonatal Research Network: Neurodevelopmental and growth impairment among extremely low-birth-weight infants with neonatal infection. JAMA 2004;292:2357-2365.
2. Watanabe E, Hirasawa H, Oda S, Matsuda K, Hatano M, Tokuhisa T: Extremely high interleukin-6 blood levels and outcome in the critically ill are associated with tumor necrosis factor- and interleukin-1-related gene polymorphisms. Crit Care Med 2005;33:89-97.
3. Stuber F, Petersen M, Bokelmann F, Schade U: A genomic polymorphism within the tumor necrosis factor locus influences plasma tumor necrosis factor-α concentrations and outcome of patients with severe sepsis. Crit Care Med 1996;24:381-384.
4. Stuber F, Udalova IA, Book M, Drutskaya LN, Kuprash DV, Turetskaya RL, Schade FU, Nedospasov SA: -308 tumor necrosis factor (TNF) polymorphism is not associated with survival in severe sepsis and is unrelated to lipopolysaccharide inducibility of the human TNF promoter. J Inflamm 1996;46:42-50.
5. Bouma G, Crusius JB, Oudkerk Pool M, Kolkman JJ, von Blomberg BM, Kostense PJ, Giphart MJ, Schreuder GM, Meuwissen SG, Pena AS: Secretion of tumour necrosis factor α and lymphotoxin α in relation to polymorphisms in the TNF genes and HLA-DR alleles: relevance for inflammatory bowel disease. Scand J Immunol 1996;43:456-463.
6. Knight JC, Keating BJ, Kwiatkowski DP: Allele-specific repression of lymphotoxin-α by activated B cell factor-1. Nat Genet 2004;36:394-399.
7. Heep A, Schueller AC, Kattner E, Kroll M, Sander J, Wisbauer M, Bartmann P, Stuber F: Association of two tumour necrosis factor gene polymorphisms with the incidence of severe intraventricular haemorrhage in preterm infants. J Med Genet 2005;42:604-608.
8. Dammann O, Durum SK, Leviton A: Modification of the infection-associated risks of preterm birth and white matter damage in the preterm newborn by polymorphisms in the tumor necrosis factor-locus? Pathogenesis 1999;1:171-177.